Global Tumor Embolization Device Market Growth 2025-2031

Publication ID:

LPI04255249

Publication Date:

April 24, 2025

Pages:

102

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Tumor Embolization Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Tumor Embolization Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Tumor Embolization Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Tumor Embolization Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Tumor Embolization Device players cover Boston Scientific Corporation, Medtronic plc., Terumo Corporation, Sirtex Medical ltd., Merit Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淭umor Embolization Device Industry Forecast鈥� looks at past sales and reviews total world Tumor Embolization Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Tumor Embolization Device sales for 2025 through 2031. With Tumor Embolization Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Embolization Device industry.
This Insight Report provides a comprehensive analysis of the global Tumor Embolization Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Embolization Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Tumor Embolization Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Embolization Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Embolization Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Embolization Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Cancer Tumors Embolization Device
Noncancerous Tumors Embolization Device
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boston Scientific Corporation
Medtronic plc.
Terumo Corporation
Sirtex Medical ltd.
Merit Medical
Cook Meidical LLC
BTG plc.
Angiodynamics
Siemens Healthineers
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tumor Embolization Device market?
What factors are driving Tumor Embolization Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tumor Embolization Device market opportunities vary by end market size?
How does Tumor Embolization Device break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tumor Embolization Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Tumor Embolization Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Tumor Embolization Device by Country/Region, 2020, 2024 & 2031
2.2 Tumor Embolization Device Segment by Type
2.2.1 Cancer Tumors Embolization Device
2.2.2 Noncancerous Tumors Embolization Device
2.3 Tumor Embolization Device Sales by Type
2.3.1 Global Tumor Embolization Device Sales Market Share by Type (2020-2025)
2.3.2 Global Tumor Embolization Device Revenue and Market Share by Type (2020-2025)
2.3.3 Global Tumor Embolization Device Sale Price by Type (2020-2025)
2.4 Tumor Embolization Device Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Tumor Embolization Device Sales by Application
2.5.1 Global Tumor Embolization Device Sale Market Share by Application (2020-2025)
2.5.2 Global Tumor Embolization Device Revenue and Market Share by Application (2020-2025)
2.5.3 Global Tumor Embolization Device Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Tumor Embolization Device Breakdown Data by Company
3.1.1 Global Tumor Embolization Device Annual Sales by Company (2020-2025)
3.1.2 Global Tumor Embolization Device Sales Market Share by Company (2020-2025)
3.2 Global Tumor Embolization Device Annual Revenue by Company (2020-2025)
3.2.1 Global Tumor Embolization Device Revenue by Company (2020-2025)
3.2.2 Global Tumor Embolization Device Revenue Market Share by Company (2020-2025)
3.3 Global Tumor Embolization Device Sale Price by Company
3.4 Key Manufacturers Tumor Embolization Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumor Embolization Device Product Location Distribution
3.4.2 Players Tumor Embolization Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Tumor Embolization Device by Geographic Region
4.1 World Historic Tumor Embolization Device Market Size by Geographic Region (2020-2025)
4.1.1 Global Tumor Embolization Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Tumor Embolization Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tumor Embolization Device Market Size by Country/Region (2020-2025)
4.2.1 Global Tumor Embolization Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Tumor Embolization Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tumor Embolization Device Sales Growth
4.4 APAC Tumor Embolization Device Sales Growth
4.5 Europe Tumor Embolization Device Sales Growth
4.6 Middle East & Africa Tumor Embolization Device Sales Growth
5 Americas
5.1 Americas Tumor Embolization Device Sales by Country
5.1.1 Americas Tumor Embolization Device Sales by Country (2020-2025)
5.1.2 Americas Tumor Embolization Device Revenue by Country (2020-2025)
5.2 Americas Tumor Embolization Device Sales by Type (2020-2025)
5.3 Americas Tumor Embolization Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Embolization Device Sales by Region
6.1.1 APAC Tumor Embolization Device Sales by Region (2020-2025)
6.1.2 APAC Tumor Embolization Device Revenue by Region (2020-2025)
6.2 APAC Tumor Embolization Device Sales by Type (2020-2025)
6.3 APAC Tumor Embolization Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tumor Embolization Device by Country
7.1.1 Europe Tumor Embolization Device Sales by Country (2020-2025)
7.1.2 Europe Tumor Embolization Device Revenue by Country (2020-2025)
7.2 Europe Tumor Embolization Device Sales by Type (2020-2025)
7.3 Europe Tumor Embolization Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tumor Embolization Device by Country
8.1.1 Middle East & Africa Tumor Embolization Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Tumor Embolization Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Tumor Embolization Device Sales by Type (2020-2025)
8.3 Middle East & Africa Tumor Embolization Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tumor Embolization Device
10.3 Manufacturing Process Analysis of Tumor Embolization Device
10.4 Industry Chain Structure of Tumor Embolization Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tumor Embolization Device Distributors
11.3 Tumor Embolization Device Customer
12 World Forecast Review for Tumor Embolization Device by Geographic Region
12.1 Global Tumor Embolization Device Market Size Forecast by Region
12.1.1 Global Tumor Embolization Device Forecast by Region (2026-2031)
12.1.2 Global Tumor Embolization Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tumor Embolization Device Forecast by Type (2026-2031)
12.7 Global Tumor Embolization Device Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Boston Scientific Corporation
13.1.1 Boston Scientific Corporation Company Information
13.1.2 Boston Scientific Corporation Tumor Embolization Device Product Portfolios and Specifications
13.1.3 Boston Scientific Corporation Tumor Embolization Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boston Scientific Corporation Main Business Overview
13.1.5 Boston Scientific Corporation Latest Developments
13.2 Medtronic plc.
13.2.1 Medtronic plc. Company Information
13.2.2 Medtronic plc. Tumor Embolization Device Product Portfolios and Specifications
13.2.3 Medtronic plc. Tumor Embolization Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Medtronic plc. Main Business Overview
13.2.5 Medtronic plc. Latest Developments
13.3 Terumo Corporation
13.3.1 Terumo Corporation Company Information
13.3.2 Terumo Corporation Tumor Embolization Device Product Portfolios and Specifications
13.3.3 Terumo Corporation Tumor Embolization Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Terumo Corporation Main Business Overview
13.3.5 Terumo Corporation Latest Developments
13.4 Sirtex Medical ltd.
13.4.1 Sirtex Medical ltd. Company Information
13.4.2 Sirtex Medical ltd. Tumor Embolization Device Product Portfolios and Specifications
13.4.3 Sirtex Medical ltd. Tumor Embolization Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sirtex Medical ltd. Main Business Overview
13.4.5 Sirtex Medical ltd. Latest Developments
13.5 Merit Medical
13.5.1 Merit Medical Company Information
13.5.2 Merit Medical Tumor Embolization Device Product Portfolios and Specifications
13.5.3 Merit Medical Tumor Embolization Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merit Medical Main Business Overview
13.5.5 Merit Medical Latest Developments
13.6 Cook Meidical LLC
13.6.1 Cook Meidical LLC Company Information
13.6.2 Cook Meidical LLC Tumor Embolization Device Product Portfolios and Specifications
13.6.3 Cook Meidical LLC Tumor Embolization Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Cook Meidical LLC Main Business Overview
13.6.5 Cook Meidical LLC Latest Developments
13.7 BTG plc.
13.7.1 BTG plc. Company Information
13.7.2 BTG plc. Tumor Embolization Device Product Portfolios and Specifications
13.7.3 BTG plc. Tumor Embolization Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BTG plc. Main Business Overview
13.7.5 BTG plc. Latest Developments
13.8 Angiodynamics
13.8.1 Angiodynamics Company Information
13.8.2 Angiodynamics Tumor Embolization Device Product Portfolios and Specifications
13.8.3 Angiodynamics Tumor Embolization Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Angiodynamics Main Business Overview
13.8.5 Angiodynamics Latest Developments
13.9 Siemens Healthineers
13.9.1 Siemens Healthineers Company Information
13.9.2 Siemens Healthineers Tumor Embolization Device Product Portfolios and Specifications
13.9.3 Siemens Healthineers Tumor Embolization Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Siemens Healthineers Main Business Overview
13.9.5 Siemens Healthineers Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂